Co-Biome Testing

The MetaXplore™ range provides healthcare professionals with a comprehensive view of diagnostic gastrointestinal markers1 and metagenomic-driven gut microbiome insights2 in an easy-to-interpret report.

Each MetaXplore™ report provides clinical1 and research insights2 with scientifically graded statements on the evidence for diet and lifestyle interventions as well as probiotic, prebiotic, nutrient and polyphenol supplementation to support clinical decision-making. To provide an accurate and comprehensive view of the whole gut microbiome, each MetaXplore™ report provides insights from the analysis of over 28,000* microbial species and their function.

*These products are only available for purchase through a healthcare professional
metaxplore products boxes
Metaxplore product image MetaXplore™ - $369

Functional Gut Microbiome Profile2

Metaxplore product image MetaXplore™ GI - $489

Gastrointestinal Health Markers1

Functional Gut Microbiome Profile2

Metaxplore product image MetaXplore™ GI Plus - $529

Gastrointestinal Health Markers1
Targeted

Pathogen & Parasite Panels1

Functional Gut Microbiome Profile2

Understand how your patients gut microbiome and gastrointestinal health is impacting

Rounded icon

Intestinal inflammation

Rounded icon

Digestive secretions

Rounded icon

Intestinal motility

Rounded icon

Systemic inflammation

Rounded icon

Detox / retox

Rounded icon

Intestinal barrier

Which MetaXplore™ profile is best for my patient?
MetaXplore™
MetaXplore™ GI
MetaXplore™ GI Plus

Comprehensive report with easy to interpret findings

tick icon
tick icon
tick icon

Metagenomic identification of 28,000+ microbial species* including including bacteria, archaea and eukaryotes (fungi and protist parasites)^

tick icon
tick icon
tick icon

Microbiome diversity, microbial richness count and relative abundance of the microbial community

tick icon
tick icon
tick icon

Personalised clinical and research insights providing scientifically graded statements on the evidence for diet and lifestyle interventions as well as probiotic, prebiotic, nutrient and polyphenol supplementation

tick icon 2
tick icon 1
tick icon 1

Presence and relative abundance of bacteria with species level identification

tick icon
tick icon
tick icon

Gut microbiome impact on intestinal inflammation, intestinal barrier, motility, systemic inflammation, digestive secretions, detox/ retox

tick icon
tick icon
tick icon

Production of microbial markers - butyrate, acetate, propionate, 3-indolepropionic acid (IPA), hexa-acylated lipopolysaccharide (hexa-LPS), trimethylamine (TMA), hydrogen sulphide, branched-chain amino acids (BCAA), B.fragilis toxin, methane, beta-glucuronidase

tick icon
tick icon
tick icon

Emerging markers - histamine, ammonia (urease), gamma-aminobutyric acid (GABA) production, GABA consumption, vitamin K, lactate, human DNA

tick icon
tick icon
tick icon

Microbiome consumption of mucin and oxalate

tick icon
tick icon
tick icon

Whole microbiome profiling of all fungi species

tick icon
tick icon
tick icon

Whole microbiome profiling of protist parasites

tick icon
tick icon
tick icon

Diagnostic gastrointestinal markers - calprotectin, faecal occult blood, lactoferrin, pancreatic elastase, secretory IgA, zonulin

cross icon
tick icon
tick icon

Investigative gastrointestinal marker - faecal pH

cross icon
tick icon
tick icon

Diagnostic identification of pathogenic bacteria

cross icon
cross icon
tick icon

Diagnostic identification of protist parasites

cross icon
cross icon
tick icon

*Can report on over 28,000 species although a typical healthy sample will contain between 110 – 244 species. ^Shotgun metagenomics can report on non-diagnostic pathogens and protists.

Why choose Co-Biome?
Clinical utility

Co-Biome is for clinicians and leverages the expertise from a team of clinicians, researchers and scientists. Combining deep gut microbiome knowledge with clinical experience transforms how clinicians can manage patient health.

Scientific thought leadership

Co-Biome use the latest technology to uncover more than ever before to guide clinicians with a more complete picture.

Data-driven approach

Co-Biome leverages insights from Microba's microbiome research to guide health insights related to the microbiome and guide future health discoveries.